EVH (Evolent Health) Interest Expense: $-65 Mil (TTM As of Mar. 2026)

What is Evolent Health Interest Expense?

Evolent Health EVH -3.31% 66 Interest Expense is $-65 Mil as of Mar. 2026. GuruFocus rates EVH with a GF Score™ of 66/100 and a GF Value™ of $11.15 (Possible Value Trap). The stock has 7 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Evolent Health's interest expense for the three months ended in Mar. 2026 was $ -17 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was $-65 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Evolent Health's Operating Income for the three months ended in Mar. 2026 was $ -11 Mil. Evolent Health's Interest Expense for the three months ended in Mar. 2026 was $ -17 Mil. Evolent Health did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Evolent Health (NYSE:EVH) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Evolent Health's Interest Expense for the three months ended in Mar. 2026 was $-17 Mil. Its Operating Income for the three months ended in Mar. 2026 was $-11 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was $977 Mil.

Evolent Health's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Evolent Health did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Evolent Health Interest Expense Historical Data

* Premium members only.

The historical data trend for Evolent Health's Interest Expense can be seen below:

Evolent Health Interest Expense Chart

Evolent Health Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Interest Expense

Get a 7-Day Free Trial

-25.43

-15.57

-54.21

-24.72

-57.47

Evolent Health Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Interest Expense	Get a 7-Day Free Trial															-10.39	-10.35	-14.12	-23.77	-16.87

66GF Score

Evolent Health Inc EVH

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Evolent Health Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-65 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of $-65 Mil mean?

Evolent Health (EVH) has a Interest Expense of $-65 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Evolent Health and its competitors.

Is Evolent Health's Interest Expense too high?

Evolent Health's current Interest Expense is $-65 Mil. Overall, Evolent Health has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Evolent Health's Interest Expense compare to PHR and CTEV?

Evolent Health's Interest Expense of $-65 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Healthcare Providers & Services company?

A good Interest Expense depends on the Healthcare Providers & Services industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Evolent Health and its competitors. Evolent Health's current Interest Expense is $-65 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Evolent Health stock overvalued right now?

Based on GuruFocus' analysis, Evolent Health (EVH) is currently considered Possible Value Trap. The stock's GF Value™ is $11.15, compared to a current price of $5.55 — trading 50.2% below its estimated fair value. The current Interest Expense is $-65 Mil. Evolent Health's overall GF Score™ is 66/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For Evolent Health (EVH), the current Interest Expense is $-65 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Evolent Health (EVH) Overvalued in 2026?

Based on GuruFocus' analysis, Evolent Health stock appears to be undervalued. The current stock price of $5.55 is trading 50.2% below its estimated GF Value™ of $11.15. GuruFocus considers Evolent Health to be Possible Value Trap.

Key valuation signals for EVH:

Interest Expense: $-65 Mil
GF Value™: $11.15 vs. price of $5.55 (50.2% below fair value)
GF Score™: 66/100 with 7 warning signs

No single metric tells the full story. See the EVH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Evolent Health Business Description

Industry Healthcare Healthcare Providers & Services

Comparable Companies PHR CTEV MDRX SOPH WEAV NRC HSTM TBRG SLP TALK VEEV ASX:PME BTSG TEM HQY TSE:2413 HNGE TXG DOCS WAY

Other Exchanges 9EH:Germany

Address 1812 North Moore Street, Suite 1705, Arlington, VA, USA, 22209

Website https://www.evolenthealth.com

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.

66GF Score

Get the complete analysis for EVH

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.55

Price

$11.15

GF Value

View EVH Analysis

See Interest Expense data for all stocks →